GSK holds block window open with $750m Aspen sale
Pharmaceutical firm GlaxoSmithKline is selling a $750m stake in South African peer Aspen Pharmacare through a block trade on Tuesday night, continuing a strong run of blocks in recent weeks.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article:
- ✔ 4,000 annual insights
- ✔ 700+ notes and long-form analyses
- ✔ 4 capital markets databases
- ✔ Daily newsletters across markets and asset classes
- ✔ 2 weekly podcasts